India in Final Stages of Launching National Policy to Promote R&D in Pharma-medical Devices Sectors: Union minister Mansukh Mandaviya

Mansukh Mandaviya, Union Health Minister, said that India is nearing completion of a national policy to boost research, development, and innovation in the pharmaceutical and medical device sectors. India's commitment to quality, accessibility, and affordability in healthcare is unwavering, as demonstrated during the Covid-19 pandemic, Mandaviya said in his keynote address on Sunday to Indian pharmaceutical industry leaders, G20 ministers, and delegates on the sidelines of the G20 health ministers meeting, which is being held here from August 17 to 19.

He also discussed India's vision for the future of healthcare, which is centred on a shift from volume-based approaches to a value-based leadership model. "Dr Mandaviya announced India's strides in fostering an innovative environment, acknowledging the paramount importance of research and development in healthcare advancement," according to a government release. "India is in the final stages of introducing a national policy to promote research and development and innovation in the pharma-medical devices sectors," according to the announcement, quoting Mandaviya. The Union minister asked governments, government bodies, industry leaders, healthcare professionals, and academics to join forces in a collaborative endeavour "to elevate the pharmaceutical and medical devices sectors to unprecedented heights." "Indian-made medicines save lives in the Netherlands, Europe, and around the world." I am looking forward to expanding my collaboration with India. "There are tremendous opportunities for collaboration in innovative medicines," stated Dr. Kuipers.

"With the capacity and knowledge that India has in generic and specific drugs, we look forward to a more integrated collaboration with India," he added. Mandaviya also met with Indonesia's Health Minister Sadikin in a bilateral discussion to discuss many problems of cooperation and partnership in the health sector. He also accompanied a delegation of G20 delegates and ministers, including the Indonesian health minister, to a Jan Aushadhi Kendra to explain India's accomplishment in providing its inhabitants with accessible, affordable, and high-quality medications. fter the visit, Sadikin told mediapersons, "I want to give the best medicines to my people in Indonesia.

I have seen many models of different countries, and India's Jan Aushadhi Kendra model is the best in the world in terms of providing quality, accessibility and affordability of medicines to the people." "I look around many countries and I confess that India has the best," he said. "In the summit, discussions were held on the Jan Aushadhi Kendra. In a scenario where the cost of healthcare and medicine is on the rise, the Indian model has been lauded by health ministers across the world for its low cost and quality medicines," Mandaviya said.